Matt Seiler, a senior consultant in our San Francisco office, recently sat down with Jason Lee, an associate principal, to have a conversation about provider financial services in its current state.
Hospitals and health systems need to understand Total Performance Score (TPS), how TPS is calculated, and how it can be used to optimize strategic decisions and increase total revenue.
As healthcare continues to shift from a volume to value orientation, observers across the country are increasingly raising concerns over how the Stark law and Anti-Kickback Statute (AKS) limit the ability of providers to participate in and be appropriately compensated for care coordination.
Results from our 2018 compensation surveys are in, and registration is now open for our 2019 surveys.
ECG’s 2018 Physician Compensation Survey provides market-specific data. This year’s data showed that the major issues motivating organizations to examine and reconfigure compensation arrangements are financial performance, migration to value based reimbursement systems, and pressures from nontraditional competitors.
For many health systems, referral leakage may equate to millions of dollars in forgone revenue, as every patient who seeks care elsewhere is a lost revenue opportunity now and potentially into the future. Learn the symptoms of an underperforming referral management system.
On January 1, the 2018 final rule regarding payment for Medicare services under the Hospital Outpatient Prospective Payment System went into effect. The Centers for Medicare & Medicaid Services (CMS) removed knee replacements from the inpatient-only list and defined an outpatient hospital reimbursement rate for these cases.
ECG is proud to have been named the number one overall management consulting firm in the 2018 Best in KLAS: Software and Services Report. This is an exciting honor that is a direct result of our clients’ feedback.
CMS released its proposal for CY 2018 Hospital Outpatient Prospective Payment System (OPPS) payment rules, containing significant changes to reimbursement for hospitals participating in the 340B Drug Pricing Program.
Page 1 of 7